The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile

BACKGROUND: Weight loss therapy is becoming more and more important, and two classes of molecules, namely amylin receptor and GLP-1 receptor agonists, have shown promise in this regard. Interestingly, these molecules have several overlapping pharmacological effects, such as suppression of gastric em...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Endocr Disord
Hlavní autoři: Larsen, Anna Thorsø, Gydesen, Sofie, Sonne, Nina, Karsdal, Morten Asser, Henriksen, Kim
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7791885/
https://ncbi.nlm.nih.gov/pubmed/33413317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-020-00678-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky